| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2727 | 2015 |
| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1862 | 2020 |
| Defining T cell states associated with response to checkpoint immunotherapy in melanoma M Sade-Feldman, K Yizhak, SL Bjorgaard, JP Ray, CG de Boer, ... Cell 175 (4), 998-1013. e20, 2018 | 1443 | 2018 |
| Adult mesenchymal stem cells and cell-based tissue engineering RS Tuan, G Boland, R Tuli Arthritis Res Ther 5, 1-14, 2002 | 1287 | 2002 |
| A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade L Jerby-Arnon, P Shah, MS Cuoco, C Rodman, MJ Su, JC Melms, ... Cell 175 (4), 984-997. e24, 2018 | 1064 | 2018 |
| Resistance to checkpoint blockade therapy through inactivation of antigen presentation M Sade-Feldman, YJ Jiao, JH Chen, MS Rooney, M Barzily-Rokni, ... Nature communications 8 (1), 1136, 2017 | 827 | 2017 |
| Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells GM Boland, G Perkins, DJ Hall, RS Tuan Journal of cellular biochemistry 93 (6), 1210-1230, 2004 | 723 | 2004 |
| CDK4/6 inhibition augments antitumor immunity by enhancing T-cell activation J Deng, ES Wang, RW Jenkins, S Li, R Dries, K Yates, S Chhabra, ... Cancer discovery 8 (2), 216-233, 2018 | 604 | 2018 |
| Toward minimal residual disease-directed therapy in melanoma F Rambow, A Rogiers, O Marin-Bejar, S Aibar, J Femel, M Dewaele, ... Cell 174 (4), 843-855. e19, 2018 | 595 | 2018 |
| Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma N Auslander, G Zhang, JS Lee, DT Frederick, B Miao, T Moll, T Tian, ... Nature medicine 24 (10), 1545-1549, 2018 | 594 | 2018 |
| Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of anti-PD-1 therapy MT Chow, AJ Ozga, RL Servis, DT Frederick, JA Lo, DE Fisher, ... Immunity 50 (6), 1498-1512. e5, 2019 | 495 | 2019 |
| Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids RW Jenkins, AR Aref, PH Lizotte, E Ivanova, S Stinson, CW Zhou, ... Cancer discovery 8 (2), 196-215, 2018 | 459 | 2018 |
| Lineage tracing in humans enabled by mitochondrial mutations and single-cell genomics LS Ludwig, CA Lareau, JC Ulirsch, E Christian, C Muus, LH Li, K Pelka, ... Cell 176 (6), 1325-1339. e22, 2019 | 430 | 2019 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 398 | 2020 |
| The human and mouse enteric nervous system at single-cell resolution E Drokhlyansky, CS Smillie, N Van Wittenberghe, M Ericsson, GK Griffin, ... Cell 182 (6), 1606-1622. e23, 2020 | 371 | 2020 |
| Spatially organized multicellular immune hubs in human colorectal cancer K Pelka, M Hofree, JH Chen, S Sarkizova, JD Pirl, V Jorgji, A Bejnood, ... Cell 184 (18), 4734-4752. e20, 2021 | 355 | 2021 |
| Molecular pathways of colon inflammation induced by cancer immunotherapy AM Luoma, S Suo, HL Williams, T Sharova, K Sullivan, M Manos, ... Cell 182 (3), 655-671. e22, 2020 | 326 | 2020 |
| Formation and prevention of postoperative abdominal adhesions GM Boland, RJ Weigel Journal of Surgical Research 132 (1), 3-12, 2006 | 315 | 2006 |
| Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma G Oliveira, K Stromhaug, S Klaeger, T Kula, DT Frederick, PM Le, ... Nature 596 (7870), 119-125, 2021 | 307 | 2021 |
| Granzyme B PET imaging as a predictive biomarker of immunotherapy response BM Larimer, E Wehrenberg-Klee, F Dubois, A Mehta, T Kalomeris, ... Cancer research 77 (9), 2318-2327, 2017 | 278 | 2017 |
George ChangProfessor of Surgical Oncology and Health Services Research, University of Texas MD Anderson Cancer在 mdanderson.org 的电子邮件经过验证
